Biopharmaceutical statistics in a pharmaceutical regulated environment: Past, present, and future

Karl E. Peace, Anthony C. Segreti, Hoi M. Leung, Gary G. Koch, Robert L. Davis, Noel R. Mohberg

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The practice of statistics in the pharmaceutical industry has changed markedly over the last 25 years. This paper examines the evolution of clinical trial statistics in relationship to advances in statistical methodology and computational power as well as the changing regulatory environment. The current role of the biopharmaceutical statistician is assessed along with the drivers for future change.
Original languageEnglish
Pages (from-to)347-372
Number of pages26
JournalJournal of Biopharmaceutical Statistics
Volume11
Issue number4
DOIs
StatePublished - Jan 1 2002

Scopus Subject Areas

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Keywords

  • FDA
  • Pharmaceutical industry
  • Regulation

Cite this